The bacterial cell envelope is a remarkable and complex structure that guards bacteria from their surrounding environment. A defining feature of Gram-negative bacteria is the presence of an outer membrane that encapsulates the peptidoglycan layer of these organisms. While the inner membrane is composed of glycerophospholipids, the outer membrane is a unique, asymmetric bilayer with glycerophospholipids confined to the inner leaflet and lipid A, a unique saccharolipid, localized to the outer leaflet. Lipid A is the lipid moiety of lipopolysaccharide (LPS) and anchors LPS to the bacterial surface. Bacteria have evolved various mechanisms to adapt to their unpredictable and often hostile surroundings, including strategies for remodeling their membrane architecture. Often these modifications provide resistance to components of the mammalian innate immune system and modulate host recognition of the invading microorganism. The lipid A domain of LPS is toxic to humans and potent stimulator of the innate immune system through via recognition by TLR4- MD2. A number of Gram-negative pathogens modify their lipid A structure to evade host detection. Additionally, structural alteration of lipid A and glycerophospholipids can directly impact bacterial resistance to innate immune effectors such as host antimicrobial peptides. The overall objective of this application is to unravel the molecular mechanisms by which Vibrio cholerae, the causative agent of the disease cholera, remodels it membrane architecture and the role this remodeling plays in virulence.
The Specific Aims of the current application are: (1) biochemical and genetic analysis of glycine modification of V. cholerae LPS; (2) Biochemical and genetic analysis of phosphoethanolamine modification of V. cholerae LPS; (3) elucidation of machinery required for phospholipid remodeling in V. cholerae; and (4) impact of V. cholerae membrane remodeling on the host innate immune response. The completion of these Aims will directly contribute to our understanding of how lipid remodeling/modification machinery impacts pathogenesis. Finally, from this work will come not only a better understanding of the disease cholera, but new avenues for vaccine development and the ability to generate engineered LPS structures that could serve as potential adjuvants and/or LPS antagonists.

Public Health Relevance

Gram-negative bacteria are responsible for a number of human infectious diseases. This includes bacteria such as Salmonella, Escherichia coli, Pseudomonas, Helicobacter pylori, and Vibrio cholerae. On the surface of these bacteria is a unique molecule called lipopolysaccharide or LPS. Much like armor, LPS helps to protect the bacterium from their surrounding environment. LPS is toxic to humans and activates the immune response. Often, gram-negative bacteria modify their LPS structure to evade detection and resist various defenses of the immune system. This application will help determine how bacteria associated with human disease modify their LPS structure possibly leading to novel therapies.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Hall, Robert H
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Georgia
Schools of Veterinary Medicine
United States
Zip Code
Crofts, Alexander A; Giovanetti, Simone M; Rubin, Erica J et al. (2018) Enterotoxigenic E. coli virulence gene regulation in human infections. Proc Natl Acad Sci U S A 115:E8968-E8976
Crofts, Alexander A; Poly, Frédéric M; Ewing, Cheryl P et al. (2018) Campylobacter jejuni transcriptional and genetic adaptation during human infection. Nat Microbiol 3:494-502
Tucker, Ashley T; Leonard, Sean P; DuBois, Cory D et al. (2018) Discovery of Next-Generation Antimicrobials through Bacterial Self-Screening of Surface-Displayed Peptide Libraries. Cell 172:618-628.e13
Crittenden, Christopher M; Herrera, Carmen M; Williams, Peggy E et al. (2018) Mapping phosphate modifications of substituted lipid A via a targeted MS3 CID/UVPD strategy. Analyst 143:3091-3099
Powers, Matthew Joseph; Trent, M Stephen (2018) Expanding the paradigm for the outer membrane: Acinetobacter baumannii in the absence of endotoxin. Mol Microbiol 107:47-56
Crittenden, Christopher M; Akin, Lucas D; Morrison, Lindsay J et al. (2017) Characterization of Lipid A Variants by Energy-Resolved Mass Spectrometry: Impact of Acyl Chains. J Am Soc Mass Spectrom 28:1118-1126
Henderson, Jeremy C; Herrera, Carmen M; Trent, M Stephen (2017) AlmG, responsible for polymyxin resistance in pandemic Vibrio cholerae, is a glycyltransferase distantly related to lipid A late acyltransferases. J Biol Chem 292:21205-21215
Herrera, Carmen M; Henderson, Jeremy C; Crofts, Alexander A et al. (2017) Novel coordination of lipopolysaccharide modifications in Vibrio cholerae promotes CAMP resistance. Mol Microbiol 106:582-596
Chen, Linxiao; Valentine, Jenny L; Huang, Chung-Jr et al. (2016) Outer membrane vesicles displaying engineered glycotopes elicit protective antibodies. Proc Natl Acad Sci U S A 113:E3609-18
Petrou, Vasileios I; Herrera, Carmen M; Schultz, Kathryn M et al. (2016) Structures of aminoarabinose transferase ArnT suggest a molecular basis for lipid A glycosylation. Science 351:608-12

Showing the most recent 10 out of 58 publications